As a member of the Central Group and Grant Awarding Coordinator, within the Net4Brain CA22103 COST Action, Dr. Milica Pešić participated in the Second Annual Meeting, held on 2-4 July 2025, at the Carol Davila University of Medicine and Pharmacy in Bucharest, Romania.
On that occasion, Dr. Milica Pešić gave a lecture "LB-100, an inhibitor of protein phosphatase 2A, sensitises glioblastoma cells to anticancer drugs by modulating P-glycoprotein expression".
It has been agreed that our Institute will host the next meeting of the Central Group in September 2025.
IBISS uses analytical cookies to analyze the use of the site in order to improve the user experience, by clicking "Accept" you consent to the use of cookies.